AngioDynamics, Inc. (ANGO) Stock Score, Valuation & Financial Research
AngioDynamics, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 25/100.
Quick answer for ANGO
AngioDynamics, Inc. currently has a Wall Street Score of 25/100. The stored market price is $15.24. Its financial score is 35/100. Its valuation score is 0/100. The latest WSS change is +0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What AngioDynamics, Inc. does
AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular th
ANGO financial snapshot
- Wall Street Score:
- 25/100
- Current price:
- $15.24
- Market capitalization:
- $629.9M
- Revenue:
- $320.2M
- Net income:
- $-36.7M
- Free cash flow:
- $508K
- Cash:
- $53.9M
- Total debt:
- $0
- EPS:
- -0.88
- Financial score:
- 35/100
- Valuation score:
- 0/100
- Revenue score:
- 7/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $508K, showing positive cash generation.
- The balance sheet shows $53.9M of cash versus $0 of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.1 points: ANGO increased 0.1 points because overall fundamentals improved.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 35/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research ANGO
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.